This site provides information on the EPIC study and details on case recruitment for veterinary professionals worldwide. Pimobendan is a prescription only medicine, licensed for the treatment of congestive heart failure due to mitral valve disease or dilated cardiomyopathy.

The EPIC Trial site is intended for veterinary professionals. By clicking 'Continue' you are affirming that you are a veterinary professional.

Evaluating Pimobendan in Cardiomegaly
Media & Journalists  •  Contact  •  Helpful Links  •  FAQs  •  Site Map

EPIC Trial News

Thursday, July 01, 2010

US EPIC Investigators Hold First Meeting

Following the ACVIM Cardiology Symposium in March 2010, the U.S. investigators for the EPIC trial held their first meeting. The three international lead investigators, Dr. Sonya Gordon, Professor Adrian Boswood and Professor Jens Häggström, managed an agenda that included discussion about the protocol, study timelines and recruitment strategies.
Read More »


Investigator Sign in

Investigators, please sign in here.